Exact Mass: 323.9875446
Exact Mass Matches: 323.9875446
Found 130 metabolites which its exact mass value is equals to given mass value 323.9875446,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Uridine 5'-monophosphate
C9H13N2O9P (324.03586580000007)
Uridine 5-monophosphate (UMP), also known as uridylic acid or uridylate, belongs to the class of organic compounds known as pyrimidine ribonucleoside monophosphates. These are pyrimidine ribobucleotides with monophosphate group linked to the ribose moiety. UMP consists of a phosphate group, a pentose sugar ribose, and the nucleobase uracil; hence, it is a ribonucleotide monophosphate. Uridine 5-monophosphate exists in all living species, ranging from bacteria to plants to humans. UMP is a nucleotide that is primarily used as a monomer in RNA biosynthesis. Uridine monophosphate is formed from Orotidine 5-monophosphate (orotidylic acid) in a decarboxylation reaction catalyzed by the enzyme orotidylate decarboxylase. Within humans, uridine 5-monophosphate participates in a number of enzymatic reactions. In particular, uridine 5-monophosphate can be converted into uridine 5-diphosphate through the action of the enzyme UMP-CMP kinase. In addition, uridine 5-monophosphate can be biosynthesized from uridine 5-diphosphate through its interaction with the enzyme soluble calcium-activated nucleotidase 1. In brain research studies, uridine monophosphate has been used as a convenient delivery compound for uridine. Uridine is present in many foods, mainly in the form of RNA. Non-phosphorylated uridine is not bioavailable beyond first-pass metabolism. In a study, gerbils fed a combination of uridine monophosphate, choline, and docosahexaenoic acid (DHA) were found to have significantly improved performance in running mazes over those not fed the supplements, implying an increase in cognitive function (PMID: 18606862). 5′-UMP. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=58-97-9 (retrieved 2024-07-02) (CAS RN: 58-97-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1].
Azamethiphos
C9H10ClN2O5PS (323.97365700000006)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents
Pseudouridine 5'-phosphate
C9H13N2O9P (324.03586580000007)
Pseudouridine (5-ribosyluracil) is a ubiquitous yet enigmatic constituent of structural RNAs (transfer, ribosomal, small nuclear, and small nucleolar). Although pseudouridine (psi) was the first modified nucleoside to be discovered in RNA, and is the most abundant, its biosynthesis and biological roles have remained poorly understood since its identification as a "fifth nucleoside" in RNA. Recently, a combination of biochemical, biophysical, and genetic approaches has helped to illuminate the structural consequences of psi in polyribonucleotides, the biochemical mechanism of U-->psi isomerization in RNA, and the role of modification enzymes (psi synthases) and box H/ACA snoRNAs, a class of eukaryotic small nucleolar RNAs, in the site-specific biosynthesis of psi. Through its unique ability to coordinate a structural water molecule via its free N1-H, psi exerts a subtle but significant "rigidifying" influence on the nearby sugar-phosphate backbone and also enhances base stacking. These effects may underlie the biological role of most (but perhaps not all) of the psi residues in RNA. Certain genetic mutants lacking specific psi residues in tRNA or rRNA exhibit difficulties in translation, display slow growth rates, and fail to compete effectively with wild-type strains in mixed culture. In particular, normal growth is severely compromised in an Escherichia coli mutant deficient in a pseudouridine synthase responsible for the formation of three closely spaced psi residues in the mRNA decoding region of the 23S rRNA. Such studies demonstrate that pseudouridylation of RNA confers an important selective advantage in a natural biological context. PMID: 10902565 [HMDB]. Pseudouridine 5-phosphate is found in many foods, some of which are garland chrysanthemum, chives, broad bean, and green bell pepper. Pseudouridine (5-ribosyluracil) is a ubiquitous yet enigmatic constituent of structural RNAs (transfer, ribosomal, small nuclear, and small nucleolar). Although pseudouridine (psi) was the first modified nucleoside to be discovered in RNA, and is the most abundant, its biosynthesis and biological roles have remained poorly understood since its identification as a "fifth nucleoside" in RNA. Recently, a combination of biochemical, biophysical, and genetic approaches has helped to illuminate the structural consequences of psi in polyribonucleotides, the biochemical mechanism of U-->psi isomerization in RNA, and the role of modification enzymes (psi synthases) and box H/ACA snoRNAs, a class of eukaryotic small nucleolar RNAs, in the site-specific biosynthesis of psi. Through its unique ability to coordinate a structural water molecule via its free N1-H, psi exerts a subtle but significant "rigidifying" influence on the nearby sugar-phosphate backbone and also enhances base stacking. These effects may underlie the biological role of most (but perhaps not all) of the psi residues in RNA. Certain genetic mutants lacking specific psi residues in tRNA or rRNA exhibit difficulties in translation, display slow growth rates, and fail to compete effectively with wild-type strains in mixed culture. In particular, normal growth is severely compromised in an Escherichia coli mutant deficient in a pseudouridine synthase responsible for the formation of three closely spaced psi residues in the mRNA decoding region of the 23S rRNA. Such studies demonstrate that pseudouridylation of RNA confers an important selective advantage in a natural biological context. PMID: 10902565.
5-O-(1-Carboxyvinyl)-3-phosphoshikimate
Uridine 3'-monophosphate
C9H13N2O9P (324.03586580000007)
Uridine 3-monophosphate (3-UMP) belongs to the class of compounds called pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. Uridine 3-monophosphate has been identified in the human placenta (PMID: 32033212). COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Uridine 2'-phosphate
C9H13N2O9P (324.03586580000007)
Uridine 2- phosphate is a product of the decylclization reaction carried out by the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses Uridine 2,3-cyclic phosphate to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1. [HMDB] Uridine 2- phosphate is a product of the decylclization reaction carried out by the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses Uridine 2,3-cyclic phosphate to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.
Dorzolamide
Dorzolamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase (CA) inhibitor. It is used in ophthalmic solutions (Trusopt) to lower intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.Dorzolamide is a sulfonamide and a highly specific carbonic anhydrase II (CA-II) inhibitor, which is the main CA isoenzyme involved in aqueous humor secretion. Inhibition of CA-II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Dorzolamide also accumulates in red blood cells as a result of CA-II binding, as CA-II is found predominantly in erythrocytes. However, sufficient CA-II activity remains so that adverse effects due to systemic CA inhibition are not observed. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor
Trichloroethanol glucuronide
C8H11Cl3O7 (323.95703460000004)
Trichloroethanol glucuronide belongs to the family of Glucuronic Acid Derivatives. These are compounds containing a glucuronic acid moeity (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid.
1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea
C14H13ClN2O3S (324.03353780000003)
[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C9H13N2O9P (324.03586580000007)
1-(3',4'-Dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor
Dulofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent
2'-Deoxy-5'-O-thiophosphonouridine
C9H13N2O7PS (324.01810780000005)
1-Propyl-1-[2-(2,4,6-trichlorophenoxy)ethyl]urea
2-prop-1-ynyl-5-(1-acetoxy-2-chloroethyl)-dithiophene|2-prop-1-ynyl-5-<1-acetoxy-2-chloroethyl>-dithiophene
(3R)-6-hydroxy-3-hydroxymethyl-2-methyl-2,3-dihydro-10H-3r,10ac-epidisulfano-pyrazino[1,2-a]indole-1,4-dione|Dehydrogliotoxin|Dehydroglyotoxin
Uridine 5-monophosphate
C9H13N2O9P (324.03586580000007)
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.085
Uridine monophosphate
C9H13N2O9P (324.03586580000007)
A pyrimidine ribonucleoside 5-monophosphate having uracil as the nucleobase. COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1].
PRZ_M325
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2007
Azamethiphos
C9H10ClN2O5PS (323.97365700000006)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents
4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]benzaldehyde
Ethyl 3-bromo-2,4,5-trifluorobenzoylacetate
C11H8BrF3O3 (323.96088740000005)
(R)-[3,4-(METHYLENEDIOXY)PHENYL]-1-BUTYLAMINEHYDROCHLORIDE
C15H17BrO3 (324.03609919999997)
3-BROMO-2-(2-FLUOROBENZYLOXY)PHENYLBOR&
C13H11BBrFO3 (323.99685980000004)
3-BROMO-2-(4-FLUOROBENZYLOXY)PHENYLBOR&
C13H11BBrFO3 (323.99685980000004)
3-(Benzyloxy)-6-bromo-2-fluorophenylboronic acid
C13H11BBrFO3 (323.99685980000004)
diethoxy-(4-methylsulfonylphenoxy)-sulfanylidene-λ5-phosphane
4-(2,4-DICHLOROPHENYL)-5-(1-METHYL-1H-PYRROL-2-YL)-4H-1,2,4-TRIAZOLE-3-THIOL
C13H10Cl2N4S (324.00032000000004)
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-5-fluoro-1-[(4-methylphenyl)sulfonyl]-
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-3-fluoro-1-[(4-methylphenyl)sulfonyl]-
4-(5-Brom-2-chlorbenzyl)phenyl-ethylether
C15H14BrClO (323.99164840000003)
3-Iodo-N-phenyl-2-pyridinecarboxamide
C12H9IN2O (323.97596139999996)
1-(4-CARBOXYPHENYL)-5-(MERCAPTOTETRAZOLE)-DISODIUMSALT
1,3-BIS(4-CHLOROPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE
methyl 3-(2,4-dinitrophenoxy)thiophene-2-carboxylate
1-bromomethyl-2-[(phenylsulfonyl)methyl]benzene
C14H13BrO2S (323.98195780000003)
5-Bromo-1H-indazole-3-carbaldehyde
C13H13BrN2O3 (324.01094880000005)
1H-Pyrrolo[2,3-b]pyridine, 3-iodo-5-(1-Methyl-1H-pyrazol-4-yl)-
Methyl 3-{[(trifluoromethyl)sulfonyl]oxy}-1H-pyrrolo[2,3-b]pyridi ne-2-carboxylate
C10H7F3N2O5S (324.00277680000005)
5-bromo-N-(4-methoxy-2-nitrophenyl)pyrazin-2-amine
trans-6-Methyl-4-ethylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide
3-[(4-CHLOROPHENYL)SULFONYL]METHYL-N-HYDROXYBENZENECARBOXIMIDAMIDE
C14H13ClN2O3S (324.03353780000003)
5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yltrifluoromethanesulfonate
C11H8F4N2O3S (324.01917460000004)
2-(4-CHLOROSULPHONYLPHENYL)ETHYLTRIMETHOXYSILANE50 IN METHYLENE CHLORIDE
C11H17ClO5SSi (324.02544620000003)
2-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]-3-FUROIC ACID
C13H6F6O3 (324.02211179999995)
3-(2-AMINO-1,3-THIAZOL-4-YL)-2H-CHROMEN-2-ONE HYDROBROMIDE
1-(3-BROMO-2-(4-FLUOROPHENYL)PROP-1-EN-1-YL)-2-CHLOROBENZENE
3-bromo-4-[(2-fluorophenyl)methoxy]benzoic acid
C14H10BrFO3 (323.97973019999995)
6-[(5-Chloro-3-methyl-1-benzofuran-2-YL)sulfonyl]pyridazin-3(2H)-one
Ethacrynate sodium
C13H11Cl2NaO4 (323.99320660000006)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics D004791 - Enzyme Inhibitors
1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea
C14H13ClN2O3S (324.03353780000003)
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide
7-[(4-Chlorophenyl)methylthio]-3-methyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one
7-[(3-Chlorophenyl)methylthio]-3-methyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one
2-(2-chloro-6-fluorobenzylthio)-4,5-dihydro-1H-imidazole hydrobromide
a 2,4-dioxotetrahydropyrimidine D-ribonucleotide
C9H13N2O9P-2 (324.03586580000007)
1-[5-(Dihydroxyphosphinothioyloxymethyl)-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
C9H13N2O7PS (324.01810780000005)
N-[(E)-(3,5-dichloro-2-hydroxyphenyl)methylidene]-2-hydroxybenzohydrazide
N-[anilino(sulfanylidene)methyl]-5-bromo-2-furancarboxamide
N-(5-bromo-2-hydroxyphenyl)-5-propyl-3-isoxazolecarboxamide
C13H13BrN2O3 (324.01094880000005)
1-(3,4-Dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea
2-Pyridinecarboxylic acid [2-(2,3-dichloroanilino)-2-oxoethyl] ester
1-(2-Bromo-1-(trifluoromethoxy)ethyl)-4-(tert-butyl)benzene
[4-[3-(3,5-Dihydroxyphenyl)oxiran-2-yl]phenyl] hydrogen sulate
Dorzolamide
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor
3-Uridylic acid
C9H13N2O9P (324.03586580000007)
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Pseudouridine 5-phosphate
C9H13N2O9P (324.03586580000007)
A C-nucleoside phosphate consisting of pseudouridine having a monophosphate group at the 5-position.
6-deoxy-6-sulfo-D-fructofuranose 1-phosphate
A carbohydrate sulfonate that is D-fructofuranose-1-phosphate in which the hydroxy group at at position 6 is replaced by a sulfo group.
Urochloralic acid
C8H11Cl3O7 (323.95703460000004)
[5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C9H13N2O9P (324.03586580000007)
3-UMP
C9H13N2O9P (324.03586580000007)
A pyrimidine ribonucleoside 3-monophosphate having uracil as the nucleobase.
Iperoxo
Iperoxo is a potent superagonist of muscarinic acetylcholine receptor (mAChR). [3H]Iperoxo can be used for direct probing activation-related conformational transitions of muscarinic receptors[1][2]. Iperoxo is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione
2-bromo-4-[(4z)-2,5-dihydroxyimidazol-4-ylidene]-1h,5h,6h,7h-pyrrolo[2,3-c]azepin-8-one
(3r,4s,5r)-5-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylic acid
[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid
C9H13N2O9P (324.03586580000007)
(1r)-2-chloro-1-[5'-(prop-1-yn-1-yl)-[2,2'-bithiophen]-5-yl]ethyl acetate
[(2s,3s,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid
C9H13N2O9P (324.03586580000007)